AAAAAA

   
Results: << | 101-125 | 126-150 | 151-175 | 176-200 | >>

Table of contents of journal: *Seminars in dialysis

Results: 101-125/595
THE NEPHROLOGIST AS A PRIMARY-CARE PROVIDER - THE PERSPECTIVE FROM THE BUSH
Authors: HULMAN PB
Citation: Pb. Hulman, THE NEPHROLOGIST AS A PRIMARY-CARE PROVIDER - THE PERSPECTIVE FROM THE BUSH, Seminars in dialysis, 10(6), 1997, pp. 326-328
THE PATIENT AS A CO-MANAGER IN THE HEALTH-CARE SYSTEM
Authors: GRUMAN J VONKORFF M
Citation: J. Gruman et M. Vonkorff, THE PATIENT AS A CO-MANAGER IN THE HEALTH-CARE SYSTEM, Seminars in dialysis, 10(6), 1997, pp. 329-334
THE ROLE OF MEDICAL SUBSPECIALISTS AS PRIMARY-CARE PROVIDERS
Authors: HECKLER TM
Citation: Tm. Heckler, THE ROLE OF MEDICAL SUBSPECIALISTS AS PRIMARY-CARE PROVIDERS, Seminars in dialysis, 10(6), 1997, pp. 335-338
THE NEPHROLOGIST AS A PRIMARY-CARE PROVIDER - FINAL THOUGHTS
Authors: PORTER GA
Citation: Ga. Porter, THE NEPHROLOGIST AS A PRIMARY-CARE PROVIDER - FINAL THOUGHTS, Seminars in dialysis, 10(6), 1997, pp. 339-339
HEPATITIS-C VIRUS - A THREAT WITHOUT A CURE TO THE PATIENT WITH ESRD
Authors: WRIGHT TL PEREIRA BJG
Citation: Tl. Wright et Bjg. Pereira, HEPATITIS-C VIRUS - A THREAT WITHOUT A CURE TO THE PATIENT WITH ESRD, Seminars in dialysis, 10(5), 1997, pp. 241-244
MIDODRINE - A NEW THERAPY FOR INTRADIALYTIC HYPOTENSION
Authors: PERAZELLA MA
Citation: Ma. Perazella, MIDODRINE - A NEW THERAPY FOR INTRADIALYTIC HYPOTENSION, Seminars in dialysis, 10(5), 1997, pp. 245-247
EMOTIONALLY-RELATED KIDNEY DONATION - AN UNDERUTILIZED RESOURCE
Authors: ARADHYE S GROSSMAN RA
Citation: S. Aradhye et Ra. Grossman, EMOTIONALLY-RELATED KIDNEY DONATION - AN UNDERUTILIZED RESOURCE, Seminars in dialysis, 10(5), 1997, pp. 248-249
REDUCING MORTALITY IN DIALYSIS PATIENTS - WHY DOES HYPERTENSION CONTINUE TO BE OVERLOOKED
Authors: SCRIBNER BH
Citation: Bh. Scribner, REDUCING MORTALITY IN DIALYSIS PATIENTS - WHY DOES HYPERTENSION CONTINUE TO BE OVERLOOKED, Seminars in dialysis, 10(5), 1997, pp. 250-250
WHEN AND HOW SHOULD DIALYSIS PATIENTS WITH ANTI-HEPATITIS-C ANTIBODIES BE TREATED
Authors: DIEGO J ROTH D
Citation: J. Diego et D. Roth, WHEN AND HOW SHOULD DIALYSIS PATIENTS WITH ANTI-HEPATITIS-C ANTIBODIES BE TREATED, Seminars in dialysis, 10(5), 1997, pp. 251-252
WHEN AND HOW SHOULD DIALYSIS PATIENTS WITH ANTI-HEPATITIS-C ANTIBODIES BE TREATED
Authors: GLICKLICH D
Citation: D. Glicklich, WHEN AND HOW SHOULD DIALYSIS PATIENTS WITH ANTI-HEPATITIS-C ANTIBODIES BE TREATED, Seminars in dialysis, 10(5), 1997, pp. 252-254
WHEN AND HOW SHOULD DIALYSIS PATIENTS WITH ANTI-HEPATITIS-C ANTIBODIES BE TREATED
Authors: HURAIB S
Citation: S. Huraib, WHEN AND HOW SHOULD DIALYSIS PATIENTS WITH ANTI-HEPATITIS-C ANTIBODIES BE TREATED, Seminars in dialysis, 10(5), 1997, pp. 254-257
WHEN AND HOW SHOULD DIALYSIS PATIENTS WITH ANTI-HEPATITIS-C ANTIBODIES BE TREATED
Authors: RAPTOPOULOUGIGI M
Citation: M. Raptopoulougigi, WHEN AND HOW SHOULD DIALYSIS PATIENTS WITH ANTI-HEPATITIS-C ANTIBODIES BE TREATED, Seminars in dialysis, 10(5), 1997, pp. 257-258
RENAL REPLACEMENT THERAPY IN CONGESTIVE-HEART-FAILURE
Authors: KISHORE KK YAGI N PAGANINI EP
Citation: Kk. Kishore et al., RENAL REPLACEMENT THERAPY IN CONGESTIVE-HEART-FAILURE, Seminars in dialysis, 10(5), 1997, pp. 259-266
CAUSES, RISKS AND THERAPY OF HYPERLIPIDEMIA IN CHRONIC DIALYSIS PATIENTS
Authors: AVRAM MM BLAUSTEIN DA
Citation: Mm. Avram et Da. Blaustein, CAUSES, RISKS AND THERAPY OF HYPERLIPIDEMIA IN CHRONIC DIALYSIS PATIENTS, Seminars in dialysis, 10(5), 1997, pp. 267-271
APPROPRIATE VITAMIN THERAPY FOR DIALYSIS PATIENTS
Authors: ROCCO MV MAKOFF R
Citation: Mv. Rocco et R. Makoff, APPROPRIATE VITAMIN THERAPY FOR DIALYSIS PATIENTS, Seminars in dialysis, 10(5), 1997, pp. 272-277
A POTPOURRI OF DRUG IDIOSYNCRASIES IN ESRD
Authors: LEWIS MJ SWAN SK
Citation: Mj. Lewis et Sk. Swan, A POTPOURRI OF DRUG IDIOSYNCRASIES IN ESRD, Seminars in dialysis, 10(5), 1997, pp. 278-281
RISKY BUSINESS - MANAGING DANGEROUS DIALYSIS PATIENTS
Authors: SUSSMAN B SPITAL A
Citation: B. Sussman et A. Spital, RISKY BUSINESS - MANAGING DANGEROUS DIALYSIS PATIENTS, Seminars in dialysis, 10(5), 1997, pp. 282-285
PHYSICAL PERFORMANCE TESTS FOR DIALYSIS PATIENTS
Authors: FITTS SS
Citation: Ss. Fitts, PHYSICAL PERFORMANCE TESTS FOR DIALYSIS PATIENTS, Seminars in dialysis, 10(5), 1997, pp. 286-290
METHOD OF ADMINISTERING AMINOGLYCOSIDES DURING HEMODIALYSIS
Authors: DAHL NV
Citation: Nv. Dahl, METHOD OF ADMINISTERING AMINOGLYCOSIDES DURING HEMODIALYSIS, Seminars in dialysis, 10(5), 1997, pp. 291-292
SAFETY OF MAGNESIUM LAXATIVES IN DIALYSIS PATIENTS
Authors: FRAZAO JM COBURN JW
Citation: Jm. Frazao et Jw. Coburn, SAFETY OF MAGNESIUM LAXATIVES IN DIALYSIS PATIENTS, Seminars in dialysis, 10(5), 1997, pp. 292-292
CONSEQUENCES OF NORMALIZING PERITONEAL-DIALYSIS DOSE
Authors: VONESH EF
Citation: Ef. Vonesh, CONSEQUENCES OF NORMALIZING PERITONEAL-DIALYSIS DOSE, Seminars in dialysis, 10(5), 1997, pp. 293-294
SHOULD VITAMIN-D BE ADDED TO MULTIVITAMINS FOR DIALYSIS PATIENTS
Authors: CUNNINGHAM J
Citation: J. Cunningham, SHOULD VITAMIN-D BE ADDED TO MULTIVITAMINS FOR DIALYSIS PATIENTS, Seminars in dialysis, 10(5), 1997, pp. 294-294
DIALYTIC THERAPY FOR THE DIABETIC ESRD PATIENT - COMPREHENSIVE CARE ESSENTIALS
Authors: FRIEDMAN EA
Citation: Ea. Friedman, DIALYTIC THERAPY FOR THE DIABETIC ESRD PATIENT - COMPREHENSIVE CARE ESSENTIALS, Seminars in dialysis, 10(4), 1997, pp. 193-202
PREPARING THE DIABETIC UREMIC PATIENT AND FAMILY FOR WHAT LIES AHEAD
Authors: MARKELL MS
Citation: Ms. Markell, PREPARING THE DIABETIC UREMIC PATIENT AND FAMILY FOR WHAT LIES AHEAD, Seminars in dialysis, 10(4), 1997, pp. 203-208
PERITONEAL-DIALYSIS FOR DIABETICS WITH FAILED KIDNEYS - LONG-TERM SURVIVAL AND REHABILITATION
Authors: KHANNA R OREOPOULOS DG
Citation: R. Khanna et Dg. Oreopoulos, PERITONEAL-DIALYSIS FOR DIABETICS WITH FAILED KIDNEYS - LONG-TERM SURVIVAL AND REHABILITATION, Seminars in dialysis, 10(4), 1997, pp. 209-214
Risultati: << | 101-125 | 126-150 | 151-175 | 176-200 | >>